Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACRE
2676
Ares Commercial Real Estate
ACRE
$257M
| $1.82M | ﹤0.01% |
117,155
+2,212
| +2% | +$32.5K |
|
|
DICE
2677
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.82M | ﹤0.01% |
95,081
+2,937
| +3% | +$52.4K |
|
2678
Relmada Therapeutics
RLMD
$574M
| $1.81M | ﹤0.01% |
66,996
+21,621
| +48% | +$447K |
|
2679
Offerpad Solutions
OPAD
$23.5M
| $1.81M | ﹤0.01% |
2,393
+59
| +3% | +$40.1K |
|
2680
Clear Secure
YOU
$5.62B
| $1.81M | ﹤0.01% |
67,159
+1,661
| +3% | +$41.2K |
|
|
BRDS
2681
DELISTED
Bird Global, Inc.
BRDS
| $1.8M | ﹤0.01% |
29,453
+1,279
| +5% | +$114K |
|
|
ENFN
2682
DELISTED
Enfusion, Inc.
ENFN
| $1.8M | ﹤0.01% |
141,662
+4,165
| +3% | +$63.6K |
|
2683
Procept Biorobotics
PRCT
$1.04B
| $1.8M | ﹤0.01% |
51,391
+1,206
| +2% | +$29K |
|
2684
RLX Technology
RLX
$2.4B
| $1.79M | ﹤0.01% |
997,576
-4,924
| -0.5% | -$14.6K |
|
|
AUD
2685
DELISTED
Audacy, Inc.
AUD
| $1.78M | ﹤0.01% |
614,956
+313,937
| +104% | +$829K |
|
2686
ESS Tech
GWH
$21.3M
| $1.77M | ﹤0.01% |
21,147
+4,517
| +27% | +$403K |
|
2687
United States Lime & Minerals
USLM
$3.32B
| $1.76M | ﹤0.01% |
75,845
+3,470
| +5% | +$83.6K |
|
2688
Atlassian
TEAM
$28B
| $1.76M | ﹤0.01% |
5,987
+474
| +9% | +$142K |
|
2689
Monte Rosa Therapeutics
GLUE
$1.36B
| $1.76M | ﹤0.01% |
125,400
+40,338
| +47% | +$560K |
|
2690
BlueLinx
BXC
$502M
| $1.75M | ﹤0.01% |
24,384
+451
| +2% | +$36.9K |
|
2691
Kodiak Sciences
KOD
$2.68B
| $1.75M | ﹤0.01% |
226,987
-10,376
| -4% | -$405K |
|
2692
TAL Education Group
TAL
$6.65B
| $1.75M | ﹤0.01% |
581,474
+17,005
| +3% | +$52.2K |
|
|
SPNS
2693
DELISTED
Sapiens International
SPNS
| $1.75M | ﹤0.01% |
68,862
+1,234
| +2% | +$35.9K |
|
|
LGTY
2694
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $1.75M | ﹤0.01% |
83,729
+1,277
| +2% | +$28.2K |
|
2695
Accuray
ARAY
$37.2M
| $1.74M | ﹤0.01% |
525,558
+12,119
| +2% | +$45.1K |
|
|
LTCH
2696
DELISTED
Latch, Inc. Common Stock
LTCH
| $1.74M | ﹤0.01% |
407,119
-34,342
| -8% | -$180K |
|
2697
Vroom Inc
VRM
$36.7M
| $1.73M | ﹤0.01% |
8,134
+218
| +3% | +$103K |
|
2698
Warby Parker
WRBY
$3.67B
| $1.73M | ﹤0.01% |
51,149
+1,251
| +3% | +$40.5K |
|
|
EGLE
2699
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $1.73M | ﹤0.01% |
25,380
+1,389
| +6% | +$73.5K |
|
2700
Phathom Pharmaceuticals
PHAT
$684M
| $1.72M | ﹤0.01% |
126,187
+2,888
| +2% | +$46.7K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.